This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Deutsches Krebsforschungszentrum, Ruprecht-Karls-Universitaet Heidelberg. Active years: 2015.
Company Filing History:
1 out of 159 
1 out of 23 
Years Active: 2015
Title: Iris Augustin: Innovator in Cancer Research
Introduction
Iris Augustin is a prominent inventor based in Dossenheim, Germany. She has made significant contributions to the field of cancer research, particularly through her innovative work on G protein-coupled receptors.
Latest Patents
Iris Augustin holds 1 patent related to her research. Her patent, titled "Gpr177 as target and marker in tumors," focuses on modulators of G protein-coupled receptor 177 (Gpr177) for use in the treatment, alleviation, prevention, and diagnosis of cancer. This invention also includes methods for diagnosing such cancers, showcasing her commitment to advancing cancer treatment.
Career Highlights
Throughout her career, Iris has worked with esteemed institutions, including Ruprecht-Karls-Universität Heidelberg and Deutsches Krebsforschungszentrum. Her work in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Iris has collaborated with notable professionals, including her coworker Michael Boutros. These partnerships have enhanced her research and expanded the impact of her innovations in cancer treatment.
Conclusion
Iris Augustin's contributions to cancer research through her patent and collaborations highlight her role as an influential inventor in the scientific community. Her work continues to pave the way for advancements in cancer diagnosis and treatment.